Ameriprise Financial Inc Atea Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 98,069 shares of AVIR stock, worth $312,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,069

Previous 101,793 3.66%

Holding current value

$312,840

Previous $336,000 2.38%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.17 - $4.02 $11,805 - $14,970	-3,724 Reduced 3.66%	98,069 $328,000
Q2 2024 Aug 14, 2024	SELL	$3.31 - $4.04 $13,322 - $16,261	-4,025 Reduced 3.8%	101,793 $336,000
Q1 2024 May 15, 2024	BUY	$3.09 - $4.56 $161,696 - $238,620	52,329 Added 97.83%	105,818 $427,000
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $32,482 - $38,863	11,601 Added 27.7%	53,489 $163,000
Q3 2023 Nov 14, 2023	SELL	$3.0 - $3.79 $21,720 - $27,439	-7,240 Reduced 14.74%	41,888 $125,000
Q2 2023 Aug 14, 2023	BUY	$3.21 - $5.06 $18,698 - $29,474	5,825 Added 13.45%	49,128 $183,000
Q1 2023 May 15, 2023	BUY	$3.0 - $4.97 $61,029 - $101,104	20,343 Added 88.6%	43,303 $145,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.17 $21 - $30	-5 Reduced 0.02%	22,960 $110,000
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $126,077 - $201,862	22,965 New	22,965 $131,000
Q4 2021 Feb 14, 2022	SELL	$7.67 - $44.59 $193,790 - $1.13 Million	-25,266 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $538,923 - $885,825	25,266 New	25,266 $885,000
Q2 2021 Aug 16, 2021	SELL	$19.22 - $59.08 $1.2 Million - $3.68 Million	-62,365 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$41.42 - $88.44 $2.02 Million - $4.32 Million	-48,811 Reduced 43.9%	62,365 $3.85 Million
Q4 2020 Feb 12, 2021	BUY	$26.36 - $41.78 $2.93 Million - $4.64 Million	111,176 New	111,176 $4.65 Million

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $266M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Atea Pharmaceuticals, Inc. Transaction History